Dermatology and Podiatry Excellence
Welcome to Medimetriks Pharmaceuticals, Inc.
Medimetriks is a leading independent specialty pharmaceutical company dedicated to the Dermatology and Podiatry markets.
We are committed to advancing patient care through the development, licensing and commercialization of innovative prescription skincare brands that fill unmet needs in the markets we serve. Our current portfolio of brands, which are promoted by our national sales force, treat conditions including acne, rosacea, atopic dermatitis, fungal infections, dystrophic nails and impetigo.
We are experts in commercialization, including creating brands, maximizing life cycles and generating value for biotech, generic and other development companies that may benefit from the depth and breadth of our relationships in Dermatology and Podiatry.
We are committed to advancing patient care through the development, licensing and commercialization of innovative prescription skincare brands that fill unmet needs in the markets we serve. Our current portfolio of brands, which are promoted by our national sales force, treat conditions including acne, rosacea, atopic dermatitis, fungal infections, dystrophic nails and impetigo.
We are experts in commercialization, including creating brands, maximizing life cycles and generating value for biotech, generic and other development companies that may benefit from the depth and breadth of our relationships in Dermatology and Podiatry.
Leadership
David Addis is the Chief Operating Officer of Medimetriks. At Bradley, Mr. Addis served as Vice President of Creative Services and was responsible for the Company’s advertising, marketing and corporate communications.
Donna Heren is the Vice President, Regulatory Affairs & Quality Assurance for Medimetriks. Ms. Heren served as Director of Regulatory Affairs at Bradley Pharmaceuticals.